Biopsy, Nerve
Nerve biopsy is not a very commonly performed procedure in the recent years due to the availability of more accurate and less invasive techniques for the diagnosis and management of many neuropathies. Targeted next-generation sequencing and whole exome sequencing have supplanted nerve biopsy in establishing the diagnosis of a inherited neurologic disorders. However, in cases where the differential diagnosis includes sarcoidosis, vasculitis, amyloidosis, inflammatory myositis, metabolic diseases etc., a nerve biopsy may be required to establish the diagnosis. In clinical practice, the indications for nerve biopsy are difficult to define and require integration of various clinical criteria, radiographic and laboratory findings to determine the clinical utility of this invasive procedure as well as selection of the nerve biopsy site.
Although any sensory nerve can be biopsied, a common practice is to biopsy the sural nerve. If a spatially heterogeneous pathology is suspected, biopsies of the superficial peroneal nerve and peroneus brevis muscle may be necessary. Radial nerve biopsy may be necessary in only selected patients. The procedure may require a short hospitalization depending on the clinical need. Complications are rare when performed in a well-equipped facility and include transient subjective and objective sensory abnormalities, pain and discomfort at the site of biopsy.
- Diagnosis and management of polyneuropathy, vasculitis, muscular dystrophy, inflammatory myositis
- Relatively indicated in the management of mitochondrial diseases and other inherited myopathies
There are no universal reference ranges for nerve biopsy specimens. In general, a normal nerve biopsy consists of endoneurium, perineurium and epineurium layers surrounded by interstitial fibrocollagenous, skeletal muscle and/or adipose connective tissue.
The nerve biopsy sample is usually divided into three parts; one part fixed in buffered formalin and then embedded in paraffin for routine histology and immunohistochemistry; second part fixed in 2.5% glutaraldehyde for electron microscopic studies; and third frozen for immunofluorescence study.
- Acta Neuropathol. 2011 Mar;121(3):313-26 [PMID: 21293868]
- Br J Neurosurg. 2013 Dec;27(6):727-34 [PMID: 23675830]
- J Peripher Nerv Syst. 2010 Jun;15(2):79-92. [PMID: 20626771]
- Handb Clin Neurol. 2013;115:155-70. [PMID: 23931779]
- Clin Neuropathol. 2012 Jan-Feb;31(1):7-23. [PMID: 22192700]